We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

Download Mobile App




Cardiac Gene Linked to Sudden Infant Death

By HospiMedica staff writers
Posted on 29 Nov 2001
A study has demonstrated that a cardiac gene is linked to sudden infant death syndrome (SIDS). More...
The study, conducted by researchers at the Mayo Clinic (Rochester, MN, USA), was published in the November 14, 2001, issue of the Journal of the American Medical Association.

Using molecular genetic testing, researchers examined tissue collected from 93 cases of SIDS or possible SIDS for a specific defect in the SCN5A gene in the heart. This gene incodes a cardiac sodium channel that acts as an electrical tunnel and controls the heart's rhythm. In two of the 93 cases, infants were found to possess SCN5A mutations. This suggests that a lethal heart rhythm disturbance may be the cause of SIDS in some cases. If further research demonstrates that 5-10% of SIDS cases may be due to such defects, it may be possible in the future to identify such at-risk infants shortly after birth by special molecular tests. Defects in the cardiac channel genes might also lead to later risk of death by congenital long QT syndrome or Brugada syndrome in adolescence if a child escapes death by SIDS during infancy.

"We're just starting to be able to identify those infants that may be at risk for SIDS and take steps to prevent the incidence of death,” said Michael J. Ackerman, M.D., a pediatric cardiologist at Mayo Clinic. "This step is one of many that could eventually prevent SIDS.




Related Links:
JAMA
Mayo Clinic

Platinum Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Newborn Hearing Screener
ALGO 7i
Portable Jaundice Management Device
Nymphaea
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.